Issue date: June 2009; Review date: June 2012.
"This guidance was developed using the single technology appraisal process."
Cetuximab for the treatment of recurrent and/or metastatic squamous cell cancer of the head and neck by National Institute for Health and Clinical Excellence. Published by National Institute for Health and Clinical Excellence in 2009. Publication and catalogue information, links to buy online and reader comments.